Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”
American Journal of Nephrology · 2024
DOI: 10.1159/000533172 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Nephrology, 2024. Verfasst von Shih-Wei Lai. Beteiligte Einrichtung: Department of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Family Medicine, China Medical University Hosp…. Hauptthemen laut MEDLINE: Febuxostat, Hyperuricemia. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
Zitieren
APA
Lai, S. W. (2024). Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”. American Journal of Nephrology. https://doi.org/10.1159/000533172
Vancouver
Lai SW. Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”. American Journal of Nephrology. 2024. doi:10.1159/000533172
BibTeX
@article{Lai2024,
author = {Lai, Shih-Wei},
title = {Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”},
journal = {American Journal of Nephrology},
year = {2024},
doi = {10.1159/000533172}
}
EUVIMED